MeSH D015785 - hereditary eye diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015785:
Hereditary eye diseases
0 Companies
0 Drugs
Success rate
D000071700:Cone-rod dystrophies
0 Companies
0 Drugs
Success rate
D000077765:Cone dystrophy
0 Companies
0 Drugs
Success rate
D000080344:Optic nerve hypoplasia
0 Companies
0 Drugs
Success rate
D000080345:Familial exudative vitreoretinopathies
0 Companies
0 Drugs
Success rate
D000080362:Stargardt disease
0 Companies
0 Drugs
Success rate
D003103:Coloboma
0 Companies
0 Drugs
Success rate
D003317:Hereditary corneal dystrophies
0 Companies
0 Drugs
Success rate
D004370:Duane retraction syndrome
0 Companies
0 Drugs
Success rate
D012162:Retinal degeneration
0 Companies
0 Drugs
Success rate
D012175:Retinoblastoma
D015418:Hereditary optic atrophies
0 Companies
0 Drugs
Success rate
D015783:Aniridia
0 Companies
0 Drugs
Success rate
D015792:Retinal dysplasia
0 Companies
0 Drugs
Success rate
D015794:Choroideremia
0 Companies
0 Drugs
Success rate
D015799:Gyrate atrophy
0 Companies
0 Drugs
Success rate
D056846:Weill-marchesani syndrome
0 Companies
0 Drugs
Success rate
D058494:Walker-warburg syndrome
0 Companies
0 Drugs
Success rate
D058540:Aicardi syndrome
0 Companies
0 Drugs
Success rate
D057826:Vitelliform macular dystrophy
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%3/3
Phase 2
20%1/5
Phase 3
0%0/1
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use